BrightSpring Health Services (NASDAQ:BTSG) PT Raised to $20.00 at UBS Group

BrightSpring Health Services (NASDAQ:BTSG) had its price objective lifted by investment analysts at UBS Group from $16.00 to $20.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the stock. UBS Group’s price objective would suggest a potential upside of 30.63% from the stock’s previous close.

Other equities analysts have also issued reports about the stock. Guggenheim boosted their price objective on shares of BrightSpring Health Services from $15.00 to $18.00 and gave the stock a “buy” rating in a report on Tuesday, October 1st. BTIG Research upped their target price on shares of BrightSpring Health Services from $15.00 to $20.00 and gave the company a “buy” rating in a research report on Thursday, October 3rd. The Goldman Sachs Group dropped their price objective on BrightSpring Health Services from $21.00 to $18.00 and set a “buy” rating for the company in a report on Friday, August 9th. Finally, KeyCorp assumed coverage on BrightSpring Health Services in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. One investment analyst has rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $16.50.

BrightSpring Health Services Price Performance

Shares of BTSG stock traded down $0.60 during trading hours on Wednesday, reaching $15.31. The stock had a trading volume of 152,417 shares, compared to its average volume of 1,459,864. BrightSpring Health Services has a 12 month low of $7.85 and a 12 month high of $16.49. The stock’s fifty day simple moving average is $14.37 and its 200 day simple moving average is $12.36. The company has a debt-to-equity ratio of 1.62, a current ratio of 1.33 and a quick ratio of 1.00.

BrightSpring Health Services (NASDAQ:BTSG) last announced its earnings results on Friday, August 2nd. The company reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.08). The company had revenue of $2.73 billion during the quarter, compared to the consensus estimate of $2.61 billion. The firm’s quarterly revenue was up 26.0% on a year-over-year basis. As a group, analysts expect that BrightSpring Health Services will post 0.57 EPS for the current year.

Insiders Place Their Bets

In other news, major shareholder Kkr Group Partnership L.P. bought 11,619,998 shares of BrightSpring Health Services stock in a transaction on Wednesday, September 11th. The shares were bought at an average cost of $11.13 per share, for a total transaction of $129,330,577.74. Following the acquisition, the insider now owns 92,959,984 shares in the company, valued at approximately $1,034,644,621.92. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Hedge Funds Weigh In On BrightSpring Health Services

A number of institutional investors and hedge funds have recently bought and sold shares of BTSG. BNP Paribas Financial Markets bought a new position in BrightSpring Health Services during the 1st quarter worth $280,000. Capstone Investment Advisors LLC acquired a new position in shares of BrightSpring Health Services during the first quarter worth approximately $9,722,000. Vanguard Group Inc. acquired a new stake in shares of BrightSpring Health Services in the 1st quarter worth approximately $54,638,000. Ameritas Investment Partners Inc. acquired a new stake in BrightSpring Health Services during the first quarter valued at approximately $58,000. Finally, American International Group Inc. bought a new stake in BrightSpring Health Services during the first quarter worth approximately $289,000.

BrightSpring Health Services Company Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.